Literature DB >> 22825534

2012 Oman Heart Association simplified guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction.

Mohammed H El-Deeb1, Abdullah M Al Riyami, Abdullah A Al Riyami, Kadhim J Sulaiman, Rashid Shahrabani, Mohamed Al Mukhaini, Najib Al Rawahi, Mohamed B Al Riyami, Adil B Al Riyami, Mansour Sallam, Said Al Hinai, Yahia Al Wahshi, Prashanth Panduranga, Abdul Malik Al Kharusi.   

Abstract

Although current practice guidelines provide an evidence-based approach to the management of acute coronary syndromes, application of the evidence by individual physicians has been suboptimal. This gap between comprehensive guidelines and actual practice stimulated Oman Heart Association to issue a simplified series for the management of the common cardiac abnormalities to be applied by the entire cardiac caregivers all over the country. This simplified approach for the management of non-ST-elevation acute coronary syndrome provides a practical and systematic means to implement evidence-based medicine into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825534     DOI: 10.1097/HPC.0b013e31825ac653

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  2 in total

Review 1.  Clinical Pathways for Non-ST Elevation Acute Coronary Syndrome in Oman: An Oman Heart Association Protocol for Hospital Quality Improvement Initiative.

Authors:  Mohammed H El-Deeb; Abdullah M Al-Riyami; Kadhim J Sulaiman; Abdullah A Al-Riyami; Mohamed Al-Mukhaini; Najib Al-Rawahi; Mohamed B Al-Riyami; Adil B Al-Riyami; Mansour Sallam; Prashanth Panduranga; Said Abdul Rahman; Said Al-Hinai; Yahia Al-Wahshi; Abdul Malik Al-Kharusi
Journal:  Oman Med J       Date:  2014-01

2.  A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines.

Authors:  Lorene Zerah; René-Sosata Bun; Sylvie Guillo; Jean-Philippe Collet; Dominique Bonnet-Zamponi; Florence Tubach
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.